Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-31

Study Completion Date

2021-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesize that

1. if decrease in SctO2 level is caused by the degree of hypothermia, SctO2 level in the 33-TH may be lower than that in the 36-TH group.
2. if decrease in SctO2 level is not caused by the degree of hypothermia but caused by brain injury, SctO2 level may be associated with only the prognosis of cardiac arrest victims regardless of core temperatures.

The primary objective of this study is to compare the 72-hour changes in SctO2 level between the 36-TH and 33-TH groups in cardiac arrest victims.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Targeted Temperature Management After In-Hospital Cardiac Arrest

NCT02578823

Hypoxic Ischemic Encephalopathy

UNKNOWN NA

Microcirculatory Perfusion in Patients With Coma After Out-of-hospital Cardiac Arrest

NCT01850485

Cardiac Arrest

COMPLETED

Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia

NCT03024021

Hypoxic-Ischemic Encephalopathy Post-Cardiorespiratory Arrest Coma Cardiac Arrest

COMPLETED

A Prospective, Multicenter Registry With Targeted Temperature Management After Out-of-hospital Cardiac Arrest in Korea

NCT02827422

Out-of-Hospital Cardiac Arrest

UNKNOWN

Measurement of Core Temperatures During Therapeutic Hypothermia

NCT01292148

Cardiac Arrest

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Subject Identification and Screening For each cohort, patients will be identified after acquisition of sustained return of spontaneous circulation (ROSC) (\> 30 minutes). If the patients meet inclusion/exclusion criteria, patients will be enrolled in the study. The investigators will obtain written informed consent from all of the patients or their representatives.
2. Assignment of Subject Number A unique identification number will be given to study subjects in an attempt to de-identify their information. Subject numbers will be assigned in sequential order. The subject number will consist of four digits. The first two digits will designate the study site. The last two digits will designate the subject by number in sequential order (i.e., subject number 01 01 will be the first subject at site 1; 01 02 will be the second subject at site 1, etc.).
3. Study Methods

* Randomization to 36-TH (core body temperature (BT) 36℃) or 33-TH (core BT 33℃) group will be performed by a web based randomization site (http://mrcc.snuh.org).
* Start target temperature management using external cooling device (Arctic Sun) within 1 hour post-ROSC.
* SctO2 monitoring starts within 1 hour post-ROSC and maintain for 72 hours.
* 36-TH (core BT 36℃) or 33-TH (core BT 33℃) for 24 hours
* Rewarming 0.25℃/h in 33-TH group
* Core temperature \< 37.5℃ for 72 hours

All patients will be treated per the postresuscitation care protocol. Target treatment will include
* Target: central venous pressure (CVP) (8 - 12 mmHg), mean arterial pressure (MAP) (\> 65 mmHg), central venous oxygen saturation (ScvO2) (\> 70%)
* Seizure control, shivering control as appropriate
* Coronary intervention as soon as possible if needed
* Infection control if indicated
* Other supportive care

Monitoring data including
* CVP, MAP, ScvO2, lactate, neuron specific enolase (NSE), end-tidal carbon dioxide (EtCO2), input-output (I/O) balance
* Intermittent electroencephalography (EEG) monitoring (2 times/72 hours)
* Laboratory data including arterial blood gas analysis (ABGA), complete blood count (CBC), liver function test (LFT), electrolyte, blood urea nitrogen/creatinine (BUN/Cr), et al.
* SctO2
* Core (esophageal or bladder) temperature
4. Data Collection

Study data will be collected in the following manner:

• All data will be collected on appropriate Case Report Forms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

From the results of previous studies, we assumed that the mean difference in rSO2 at 72 h between the 36℃ or 33℃ groups would be 3% with 4% of standard deviation. By a referral (2015-0207) to the Medical Research Collaborating Center (MRCC) of SNUH/SNUMC, a sample size of at least 58 (29 per group) was calculated with a power of 0.8 and a significance level of 0.05. Considering an unexpected loss of 15%, the study was planned for 66 participants.

Randomization was performed by the 4, 6-block randomization method at the MRCC SNUH/SNUMC web-site (http://mrcc.snu.ac.kr).

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Primary and secondary outcomes were assessed by an investigator blinded to this study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

36-TH

Core temperature 36℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.

Group Type ACTIVE_COMPARATOR

Arctic Sun

Intervention Type DEVICE

Targeted temperature management for 24 hours with core temperature 36℃ or 33℃

33-TH

Core temperature 33℃ of targeted temperature management (36-TH) for 24 hours in cardiac arrest victims using Arctic Sun.

Group Type ACTIVE_COMPARATOR

Arctic Sun

Intervention Type DEVICE

Targeted temperature management for 24 hours with core temperature 36℃ or 33℃

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arctic Sun

Targeted temperature management for 24 hours with core temperature 36℃ or 33℃

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

External cooling device

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Comatose patients successfully resuscitated from cardiac arrest

Exclusion Criteria

* \< 18 years old
* Definite non-cardiac cause arrest
* Contraindication to TH Active bleeding, coagulopathy, fatal arrhythmia, severe infectious condition
* Presence of advanced directives to withhold or withdraw life-sustaining treatment
* Expected survival \< 72 hours
* Underlying low CPC (≤ 3)
* No informed consent
* Follow-up loss

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No